Matthew Sydney - Net Worth and Insider Trading

Matthew Sydney Net Worth

The estimated net worth of Matthew Sydney is at least $8,089 dollars as of 2024-04-19. Matthew Sydney is the Exec VP, Sales & Marketing of HealthEquity Inc and owns about 100 shares of HealthEquity Inc (HQY) stock worth over $8,089. Details can be seen in Matthew Sydney's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Matthew Sydney has not made any transactions after 2016-11-01 and currently still holds the listed stock(s).

Transaction Summary of Matthew Sydney

To

Matthew Sydney Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Matthew Sydney owns 1 companies in total, including HealthEquity Inc (HQY) .

Click here to see the complete history of Matthew Sydney’s form 4 insider trades.

Insider Ownership Summary of Matthew Sydney

Ticker Comapny Transaction Date Type of Owner
HQY HealthEquity Inc 2016-11-01 Exec VP & Sales & Marketing

Matthew Sydney Latest Holdings Summary

Matthew Sydney currently owns a total of 1 stock. Matthew Sydney owns 100 shares of HealthEquity Inc (HQY) as of November 1, 2016, with a value of $8,089.

Latest Holdings of Matthew Sydney

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HQY HealthEquity Inc 2016-11-01 100 80.89 8,089

Holding Weightings of Matthew Sydney


Matthew Sydney Form 4 Trading Tracker

According to the SEC Form 4 filings, Matthew Sydney has made a total of 0 transactions in HealthEquity Inc (HQY) over the past 5 years. The most-recent trade in HealthEquity Inc is the sale of 25,000 shares on November 1, 2016, which brought Matthew Sydney around $813,000.

Insider Trading History of Matthew Sydney

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Matthew Sydney Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Matthew Sydney Ownership Network

Ownership Network List of Matthew Sydney

No Data

Ownership Network Relation of Matthew Sydney


Matthew Sydney Owned Company Details

What does HealthEquity Inc do?

Who are the key executives at HealthEquity Inc?

Matthew Sydney is the Exec VP & Sales & Marketing of HealthEquity Inc. Other key executives at HealthEquity Inc include director & President and CEO Jon Kessler , Executive VP & GC & Corp. Secy. Delano Ladd , and EVP & Chief Technology Officer Elimelech Rosner .

HealthEquity Inc (HQY) Insider Trades Summary

Over the past 18 months, Matthew Sydney made no insider transaction in HealthEquity Inc (HQY). Other recent insider transactions involving HealthEquity Inc (HQY) include a net sale of 13,540 shares made by Delano Ladd , a net sale of 127,401 shares made by Jon Kessler , and a net sale of 14,171 shares made by Elimelech Rosner .

In summary, during the past 3 months, insiders sold 71,322 shares of HealthEquity Inc (HQY) in total and bought 0 shares, with a net sale of 71,322 shares. During the past 18 months, 323,175 shares of HealthEquity Inc (HQY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 323,175 shares.

HealthEquity Inc (HQY)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

HealthEquity Inc Insider Transactions

No Available Data

Matthew Sydney Mailing Address

Above is the net worth, insider trading, and ownership report for Matthew Sydney. You might contact Matthew Sydney via mailing address: 15 W. Scenic Pointe Dr., Ste. 100, Draper Ut 84020.

Discussions on Matthew Sydney

No discussions yet.